JAMA analysis stirs debate

A JAMA analysis questioning the effectiveness of antidepressants has renewed debate.

The meta-analysis found that antidepressents are useful for those with severe depression symptoms but don't work any better than placebo in mild cases. In a letter to The New York Times, Weill Cornell psychiatry professor Dr. Richard Friedman derided the research for including only two drugs and for excluding studies that screened out placebo responders.

Two of the researchers defended their methodology, saying many approved antidepressants vary little in effectiveness and that their aim was to estimate effects of medications vs. placebos.

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.